(Q64183497)
Statements
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Trial to Evaluate the Efficacy, Safety, and Tolerability of Tralokinumab Monotherapy in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) Who Are Candidates for Systemic Therapy (English)
0 references
19 June 2018
0 references
4 July 2019
0 references
294
0 references
12 year
0 references
17 year
0 references